Sildenafil for fetal growth retardation

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 30 Mar 2017: Trial started, NCT03177824
  2. 1 Jun 2017: Trial started, NCT03230162
  3. 6 Jun 2017: Trial registered, NCT03177824
  4. 26 Jul 2017: Trial registered, NCT03230162

The trials

NCT03177824: Sildenafil Citrate for Treatment of Growth-restricted Fetuses

State
State not given
Phase
Phase 3
People
60 planned
Started
30 Mar 2017
Primary completion
30 Sep 2017
Arms
S
Results
None posted
  1. 30 Mar 2017: Trial started
  2. 6 Jun 2017: Trial registered

NCT03230162: Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

State
State not given
Phase
Phase 3
People
100 planned
Started
1 Jun 2017
Primary completion
1 May 2018
Arms
sildenafil citrate
Results
None posted
  1. 1 Jun 2017: Trial started
  2. 26 Jul 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Aphrodil, Patrex, Sildenafil actavis, Sildenafil ratiopharm, Sildenafil teva, Sildenafil Citrate 25Mg Tab, Vizarsin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.